Meissa Allali
About Meissa Allali
Meissa Allali is a Junior Product Manager in Immuno-Oncology, specializing in lung cancer, with a background in respiratory and nutritional product management.
Title
Meissa Allali currently holds the position of Chef De Produit Junior En Immuno Oncologie, Cancer Bronchique. In this role, they focus on the management and development of products related to lung cancer in the field of immuno-oncology.
Education and Expertise
Meissa Allali has a comprehensive educational background starting with a two-year preparatory course at CPP - La Prépa des INP from 2010 to 2012. This was followed by a three-year program at École Nationale Supérieure des Ingénieurs en Arts Chimiques et Technologiques, culminating in a Master's degree from the same institution in 2015. Additionally, Allali attended TBS Education for a year from 2016 to 2017. Their academic journey has given them a strong foundation in chemical engineering and technology.
Background
Meissa Allali has worked in several key roles within the pharmaceutical industry. They started as a Chef de Gamme Respiratoire et Nutrition, where they managed respiratory and nutritional products. They then transitioned to Bristol-Myers Squibb as a Chef de Produit Junior in Immuno-Oncologie, focusing on bronchial cancer. This combination of roles demonstrates substantial expertise in both respiratory and nutrition product management, along with a focused experience in immuno-oncology.
Experience in Immuno-Oncology
During their tenure at Bristol-Myers Squibb, Meissa Allali specialized in immuno-oncology, specifically targeting lung cancer. This role involved the management and strategic development of products designed to treat bronchial cancer, highlighting their capability to work in highly specialized areas of healthcare.
Experience in Respiratory and Nutritional Product Management
Meissa Allali has demonstrated proficiency in managing products related to respiratory and nutritional health. In their role as Chef de Gamme Respiratoire et Nutrition, they were responsible for handling a portfolio of products aimed at improving both respiratory and nutritional health outcomes. This role underscores their versatility and ability to oversee complex product lines in the pharmaceutical industry.